{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:38:02Z","timestamp":1740181082226,"version":"3.37.3"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024113","name":"University of Belgrade","doi-asserted-by":"publisher","award":["470\/II-4"],"award-info":[{"award-number":["470\/II-4"]}],"id":[{"id":"10.13039\/501100024113","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cjcopen.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cjco.2024.10.001","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T19:20:10Z","timestamp":1728501610000},"page":"10-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic Impact of Insulin-Treated and Non\u2013Insulin-Treated Diabetes in Patients with a Reduced Ejection Fraction After ST-Elevation Myocardial Infarction"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7526-1641","authenticated-orcid":false,"given":"Lidija","family":"Savic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Mrdovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milika","family":"Asanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanja","family":"Stankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratko","family":"Lasica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordana","family":"Krljanac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damjan","family":"Simic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2024.10.001_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/2048872613507149","article-title":"The prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial","volume":"3","author":"Ng","year":"2014","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.cjco.2024.10.001_bib2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.recesp.2020.08.006","article-title":"STEMI, primary percutaneous coronary intervention and recovering of life expectancy: insights from the SurviSTEMI study","volume":"74","author":"Pascual","year":"2021","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.cjco.2024.10.001_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijcard.2016.04.182","article-title":"A\u00a0systematic review and meta-regression of temporal trends in the excess mortality associated with diabetes mellitus after myocardial infarction","volume":"217","author":"Bauters","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjco.2024.10.001_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/2048872618803701","article-title":"High-risk myocardial infarction database initiative. editor's choice\u2014impact of insulin-treated diabetes on cardiovascular outcomes following high-risk myocardial infarction","volume":"8","author":"Rossello","year":"2019","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.cjco.2024.10.001_bib5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/ejhf.797","article-title":"A\u00a0history of diabetes predicts outcomes following myocardial infarction: an analysis of the 28 771 patients in the High-Risk MI Database","volume":"19","author":"Tajik","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjco.2024.10.001_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12872-016-0454-5","article-title":"Impact of diabetes and hypertension on cardiovascular outcomes in patients with coronary artery disease receiving percutaneous coronary intervention","volume":"17","author":"Lin","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cjco.2024.10.001_bib7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.clinthera.2015.12.006","article-title":"Effects on all-cause mortality and cardiovascular outcomes in patients with type 2 diabetes by comparing insulin with oral hypoglycemic agent therapy: a meta-analysis of randomized controlled trials","volume":"38","author":"Li","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.cjco.2024.10.001_bib8","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/dom.13002","article-title":"Relationship between diabetes and ischaemic injury among patients with revascularized ST-elevation myocardial infarction","volume":"19","author":"Reinstadler","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.cjco.2024.10.001_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/1479164120973676","article-title":"Diabetes, metformin and glucose lowering therapies after myocardial infarction: insights from the SWEDEHEART registry","volume":"17","author":"Ritsinger","year":"2020","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.cjco.2024.10.001_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12933-022-01608-3","article-title":"Long-term cardiovascular prognosis of patients with type 1 diabetes after myocardial infarction","volume":"21","author":"Kerola","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cjco.2024.10.001_bib11","first-page":"742","article-title":"Prognostic implications of type 2 diabetes mellitus in heart failure with mildly reduced ejection fraction","volume":"13","author":"Schupp","year":"2024","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.cjco.2024.10.001_bib12","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.2147\/DMSO.S339209","article-title":"Role of diabetes mellitus in acute coronary syndrome patients with heart failure and midrange ejection fraction who have undergone percutaneous coronary intervention: a 3-year case-series follow-up retrospective study","volume":"14","author":"Li","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.cjco.2024.10.001_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4244\/EIJV10I1A15","article-title":"Long-term mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in patients with insulin-treated versus non-insulin-treated diabetes mellitus","volume":"10","author":"Hoebers","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.cjco.2024.10.001_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/2048872613514013","article-title":"Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the clinical center of serbia STEMI register","volume":"3","author":"Mrdovic","year":"2014","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.cjco.2024.10.001_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur. Heart J"},{"key":"10.1016\/j.cjco.2024.10.001_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2017.07.039","article-title":"Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality","volume":"245","author":"Rossell\u00f3","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjco.2024.10.001_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/2048872615598632","article-title":"Heart failure in patients with diabetes undergoing primary percutaneous coronary intervention","volume":"5","author":"Massalha","year":"2016","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.cjco.2024.10.001_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.amjcard.2021.02.025","article-title":"Comparison of long-term outcomes after percutaneous coronary intervention in patients with insulin-treated versus non-insulin treated diabetes mellitus","volume":"148","author":"Biswas","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2024.10.001_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/hrt.2004.059675","article-title":"Primary percutaneous coronary intervention for patients with acute ST elevation myocardial infarction with and without diabetes mellitus","volume":"92","author":"van der Schaaf","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.cjco.2024.10.001_bib20","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.amjcard.2004.01.050","article-title":"Impact of insulin-requiring diabetes mellitus on effectiveness of reperfusion and outcome of patients undergoing primary percutaneous coronary intervention for acute myocardial infarction","volume":"93","author":"Antoniucci","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2024.10.001_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12933-015-0300-6","article-title":"Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis","volume":"14","author":"Bundhun","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cjco.2024.10.001_bib22","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/ejhf.347","article-title":"Efficacy and safety of ivabradine in patients with chronic systolic heart failure and diabetes: an analysis from the SHIFT trial","volume":"17","author":"Komajda","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjco.2024.10.001_bib23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0735-1097(01)01408-5","article-title":"Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction","volume":"38","author":"Dries","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2024.10.001_bib24","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.CIR.91.3.635","article-title":"Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus","volume":"91","author":"Nahser","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2024.10.001_bib25","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0195-668X(02)00828-X","article-title":"Under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction","volume":"24","author":"Norhammar","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2024.10.001_bib26","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"McDonaghTA","year":"2023","journal-title":"Eur Heart J"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X24004438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X24004438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:38:31Z","timestamp":1736210311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X24004438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2589790X24004438"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2024.10.001","relation":{},"ISSN":["2589-790X"],"issn-type":[{"type":"print","value":"2589-790X"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Impact of Insulin-Treated and Non\u2013Insulin-Treated Diabetes in Patients with a Reduced Ejection Fraction After ST-Elevation Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2024.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}